Sinclair Pharma Plc Ord 1P is listed on the London Stock Exchange trading with ticker code SPH.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £16,121m, with approximately 504m shares in issue. Over the last year, Sinclair Pharma Plc share price has been traded in a range of 17.55, hitting a high of 32.00, and a low of 14.45.
Sinclair Pharma Plc, officially known as Sinclair Pharma Plc Ord 1P was formed in July of 1999, making the company twenty years old. The company filed its latest accounts on 30th June 2014, showing a turnover of approximately 63.56 million GBX with gross profits of 35.76 million, or 0.0710 per issued share, and a pre-tax profit margin of -6.99%. Sinclair Pharma Plc currently has 5 directors, and has had 13 previous directors over the last 20 years. In the last set of accounts produced by Pricewaterhousecoopers Llp, the company showed 12.50 million paid in salaries to the 161 staff (average wage of 78 thousand), with the directors receiving an average 622 thousand each. In the accounts filed in 2014, the company paid 0 in dividends.
Sinclair Pharma Plc is in the Medicine and Biotech Research sector.
|Renew Holdings Plc (RNWH.L)|
|Redcentric Plc (RCN.L)|
|Oxford Biomedica Plc (OXB.L)|
|Mytrah Energy Limited (MYT.L)|
|Safestyle Uk Plc (SFE.L)|
|Shares in Issue||504m|
|52 Week High||32.00|
|52 Week Low||14.45|